These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22063384)
1. Sugammadex(®): new questions on reversion. Maria Simões de Almeida C; de Figueiredo Locks G Rev Bras Anestesiol; 2011; 61(6):829-31. PubMed ID: 22063384 [No Abstract] [Full Text] [Related]
2. Sugammadex: new questions on reversal. Almeida MC; Locks Gde F Rev Bras Anestesiol; 2012 Jul; 62(4):593-5. PubMed ID: 22793975 [No Abstract] [Full Text] [Related]
3. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block. Hogg RM; Mirakhur RK Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771 [TBL] [Abstract][Full Text] [Related]
4. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy. Baldo BA; McDonnell NJ; Pham NH Clin Exp Allergy; 2011 Dec; 41(12):1663-78. PubMed ID: 21732999 [TBL] [Abstract][Full Text] [Related]
5. Sugammadex: good drugs do not replace good clinical practice. Hemmerling TM; Geldner G Anesth Analg; 2007 Nov; 105(5):1506; author reply 1506-7. PubMed ID: 17959991 [No Abstract] [Full Text] [Related]
6. [Sugammadex: a new approach to the use of neuromuscular blockers]. Alvarez-Gómez JA; Veiga-Ruiz G Rev Esp Anestesiol Reanim; 2011 Jun; 58 Suppl 2():20-3. PubMed ID: 21916086 [No Abstract] [Full Text] [Related]
7. Sugammadex. Karalapillai D; Kaufman M; Weinberg L Crit Care Resusc; 2013 Mar; 15(1):57-62. PubMed ID: 23432503 [TBL] [Abstract][Full Text] [Related]
8. [Sugammadex, a revolutionary new drug to reverse neuromuscular block]. Alvarez Gómez JA Rev Esp Anestesiol Reanim; 2007 Apr; 54(4):205-7. PubMed ID: 17518169 [No Abstract] [Full Text] [Related]
9. Is the effect of sugammadex always rapid in onset? Van Gestel L; Cammu G Acta Anaesthesiol Belg; 2013; 64(2):41-7. PubMed ID: 24191525 [TBL] [Abstract][Full Text] [Related]
10. Sugammadex: the good, the bad and the ugly. Vercauteren M Acta Anaesthesiol Belg; 2013; 64(2):39-40. PubMed ID: 24191524 [No Abstract] [Full Text] [Related]
11. [Sugammadex in a patient with Takotsubo cardiomyopathy]. Navarro García L; Londoño Parra M; García Gregorio N; Díaz Cambronero O; Errando Oyonarte CL Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):625-6. PubMed ID: 22263414 [No Abstract] [Full Text] [Related]
12. Neuromuscular transmission: new concepts and agents. de Boer HD J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537 [TBL] [Abstract][Full Text] [Related]
13. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567 [TBL] [Abstract][Full Text] [Related]
15. [Sugammadex used in a patient with hereditary spastic paraplegia]. Ortega U; Renedo P; Figueroa G; Aguirre J Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):619-20. PubMed ID: 22263409 [No Abstract] [Full Text] [Related]
16. Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions. Akha AS; Rosa J; Jahr JS; Li A; Kiai K Anesthesiol Clin; 2010 Dec; 28(4):691-708. PubMed ID: 21074746 [TBL] [Abstract][Full Text] [Related]
17. Sugammadex: an opportunity to change the practice of anesthesiology? Miller RD Anesth Analg; 2007 Mar; 104(3):477-8. PubMed ID: 17312188 [No Abstract] [Full Text] [Related]
18. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex. Ren WH; Jahr JS Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969 [TBL] [Abstract][Full Text] [Related]
19. Molecule of the month. Sugammadex sodium. Drug News Perspect; 2007 Nov; 20(9):591-2. PubMed ID: 18176664 [No Abstract] [Full Text] [Related]
20. [A case of rocuronium-induced anaphylactic shock, improved by sugammadex]. Badaoui R; Popov I; Dupont H Can J Anaesth; 2012 Sep; 59(9):909-10. PubMed ID: 22653841 [No Abstract] [Full Text] [Related] [Next] [New Search]